Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

David Leung

Gastroenterology Minneapolis, MN Medical Doctor

NPI 1215469127 CMS profile 11304264

715 S 8Th St, Minneapolis, MN 55404

Open in the dashboard

General payments

$11,923

176 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Leung of Minneapolis, MN is reported in the CMS Open Payments database as having received $11,923 across 176 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,000 37
2024 General $3,933 38
2023 General $1,405 44
2022 General $1,039 40
2021 General $546 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Leung
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to David Leung were reported at $5,000. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year David Leung Gastroenterology median Middle half National median
2019 $0 $417 $126–$1,100 $163
2020 $0 $224 $74–$624 $114
2021 $546 $352 $106–$1,054 $132
2022 $1,039 $448 $129–$1,270 $149
2023 $1,405 $533 $150–$1,390 $160
2024 $3,933 $605 $160–$1,606 $164
2025 $5,000 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $5,461 31 payments
  2. Olympus Corporation of the Americas $3,112 22 payments
  3. AbbVie, Inc. $1,266 41 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $828 30 payments
  5. Regeneron Healthcare Solutions, Inc. $318 9 payments
  6. Pfizer Inc. $213 9 payments
  7. Genzyme Corporation $170 6 payments
  8. Intercept Pharmaceuticals, Inc. $137 8 payments
  9. Merck Sharp & Dohme Corporation $136 7 payments
  10. Gilead Sciences, Inc. $71 1 payment
  11. Other $212 12 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $6,353 27 payments
  2. Food and Beverage $5,570 149 payments
Products named General payments · program years 2021–2025
  1. Single Use Electrosurgical Knife KD-655 $3,112 22 payments
  2. DISPOSABLE DISTAL ATTACHMENT $3,112 22 payments
  3. Olympus $1,968 13 payments
  4. Axios $1,816 7 payments
  5. OverStitch Endoscopic Suturing System $1,579 7 payments
  6. EXALT Model D $1,489 9 payments
  7. ENTYVIO $566 20 payments
  8. LINZESS $452 18 payments
  9. CREON $415 17 payments
  10. RINVOQ $306 12 payments
  11. Other $2,158 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

28

Median for Gastroenterology: 569

Drug cost

$31,587

Median for Gastroenterology: $104,976

Branded share of claims

100%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Creon Lipase/Protease/Amylase Brand 15 $31,527
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 13 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$4,891

Medicare's payments for the services billed

Medicare patients

28

Average age 67

Services billed

44

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 46%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 12 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
  • AbbVie, Inc. $136
$136 — —
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $77
$77 — —
LINZESS
  • AbbVie, Inc. $58
  • Ironwood Pharmaceuticals, Inc $17
$74 — —
CREON
  • AbbVie, Inc. $58
$58 15 —
STELARA
  • Janssen Biotech, Inc. $37
$37 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 12 in the dashboard with a free account

Records

176 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record